| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
M.VVWTDFER.S 3.22 5.91 526.2722 87.20 - 92.64 2 1.6E7 88.66 2 9 N
K.MDYEVVGPAALTR.C 4.90 3.51 711.3690 91.42 - 96.49 2 1.5E7 93.09 19 31 N
R.STIQDIFSK.M 2.81 4.20 519.7846 88.30 - 93.48 2 1.4E7 89.63 10 18 N
Y.NAAAIMGNPMVAK.H 4.86 58.68 644.3396 72.68 - 75.80 2 4E6 74.09 51 63 N
K.HGTTILHGLDR.G 0.31 7.22 407.2268 47.52 - 54.35 3 3.1E6 51.17 64 74 N
K.MDYEVVGPAALTR.C 3.53 3.31 474.5818 91.46 - 96.71 3 2.3E6 93.12 19 31 N
K.HGTTILHGLDR.G 3.32 11.71 610.3377 46.76 - 53.82 2 2.2E6 49.98 64 74 N
R.STIQDIFSK.M 3.23 5.47 1038.5591 88.30 - 93.44 1 1.9E6 89.59 10 18 N
K.AFTGEVQAAFQK.F 1.73 12.32 648.8404 79.45 - 86.49 2 1.8E6 80.84 122 133 N
R.CLIVYPWTQR.Y 1.96 1.16 639.8453 113.19 - 120.04 2 1.7E6 114.69 32 41 N
K.LHVDPDNFK.L 3.02 41.43 542.7833 52.94 - 58.26 2 1.5E6 55.50 97 105 N
K.LHVDPDNFK.L 3.36 25.85 362.1899 52.94 - 58.15 3 1.4E6 55.50 97 105 N
K.NMDDLK.A 3.02 60.00 368.1755 34.60 - 39.69 2 1.2E6 36.93 78 83 N
K.FLAVVVSSLGR.Q 2.33 46.51 574.3514 107.84 - 114.17 2 1.2E6 108.64 134 144 N
M.VVWTDFER.S 3.88 3.91 1051.5323 87.39 - 92.97 1 1.2E6 88.73 2 9 N
R.C(+57.02)LIVYPWTQR.Y 2.63 10.28 668.3541 110.05 - 112.85 2 8.1E5 111.53 32 41 N Carbamidomethylation
K.H(+43.01)GTTILHGLDR.G 2.98 21.41 421.5633 62.32 - 66.03 3 8.1E5 64.36 64 74 N Carbamylation
R.YFGNFGNLYNAAAIMGNPMVAK.H 2.86 60.00 788.3905 131.38 - 134.02 3 7.5E5 133.09 42 63 N
M.V(+43.01)VWTDFER.S 2.09 1.93 547.7724 126.08 - 130.16 2 5.9E5 127.53 2 9 N Carbamylation
K.NMDDLK.A 0.83 10.21 735.3430 32.88 - 40.07 1 5.6E5 35.74 78 83 N
R.S(+43.01)TIQDIFSK.M 2.47 10.69 541.2859 111.68 - 115.76 2 5.5E5 113.21 10 18 N Carbamylation
K.M(+43.01)DYEVVGPAALTR.C 2.21 10.11 732.8693 111.05 - 115.47 2 4.4E5 112.77 19 31 N Carbamylation
K.MDYEVVGPAALTR.C 2.50 4.31 1421.7211 91.46 - 96.24 1 4.3E5 93.16 19 31 N
R.C(+43.01)LIVYPWTQR.Y 2.07 1.37 661.3475 111.57 - 115.19 2 4.1E5 113.22 32 41 N Carbamylation
R.C(+42.01)LIVYPWTQR.Y 2.24 0.68 660.8567 120.28 - 123.76 2 3.9E5 121.77 32 41 N Acetylation (Protein N-term)
Y.AELSVLHSEK.L 2.25 41.23 556.8095 46.45 - 52.31 2 3.2E5 49.60 87 96 N
Y.AELSVLHSEK.L 1.84 14.27 371.5407 46.45 - 52.31 3 3E5 49.61 87 96 N
K.H(+43.01)GTTILHGLDR.G 2.19 28.83 631.8437 62.32 - 66.40 2 3E5 64.36 64 74 N Carbamylation
R.YFGNFGNLYNAAAIMGNPMVAK.H 1.44 45.29 1182.0805 133.04 - 135.41 2 2.9E5 133.93 42 63 N
K.AFTGEVQAAFQK.F 2.29 25.23 432.8961 79.52 - 85.36 3 2.7E5 80.92 122 133 N
K.MDYE(+21.98)VVGPAALTR.C 2.21 3.29 481.9076 91.35 - 97.05 3 2.5E5 93.35 19 31 N Sodium adduct
Y.N(+43.01)AAAIMGNPMVAK.H 1.01 15.12 665.8445 93.75 - 97.15 2 2.5E5 95.34 51 63 N Carbamylation
R.STIQD(+21.98)IFSK.M 2.34 4.08 530.7741 88.37 - 93.44 2 2.1E5 89.65 10 18 N Sodium adduct
R.S(+43.01)TIQDIFSK.M 1.99 5.27 1081.5615 111.38 - 114.97 1 1.9E5 113.21 10 18 N Carbamylation
M.VVWTDFER.S 0.55 5.05 526.2725 85.78 - 93.28 2 1.7E5 87.63 2 9 N
K.L(+43.01)HVDPDNFK.L 2.10 60.00 564.2854 78.67 - 81.27 2 1.7E5 80.13 97 105 N Carbamylation
Y.NAAAIMGNPMVAK.H 2.40 60.00 429.8940 72.65 - 76.17 3 1.6E5 74.06 51 63 N
M.V(+43.01)VWTDFER.S 2.00 3.74 1094.5366 126.19 - 128.81 1 1.4E5 127.33 2 9 N Carbamylation
Y.NAAAIMGNPMVAK.H 3.08 57.09 1287.6644 72.58 - 76.38 1 1.4E5 74.04 51 63 N
K.LLSDCLTIVVAAK.L 0.61 3.63 673.3981 126.83 - 133.85 2 1.4E5 128.66 106 118 N
MVVWTDFER.S 2.14 5.36 591.7915 104.24 - 108.08 2 1.2E5 106.08 1 9 N
R.C(+43.01)(+45.99)LIVYPWTQR.Y 1.88 2.13 684.3403 112.56 - 115.68 2 1.1E5 114.30 32 41 N Carbamylation; Beta-methylthiolation
Y.EVVGPAALTR.C 2.00 3.28 506.7976 59.54 - 64.18 2 8.2E4 61.99 22 31 N
D.YEVVGPAALTR.C 1.28 1.71 588.3309 75.94 - 79.95 2 8.1E4 78.05 21 31 N
R.S(+43.01)TIQD(+21.98)IFSK.M 1.54 4.10 552.2778 111.78 - 115.33 2 8E4 113.20 10 18 N Carbamylation; Sodium adduct
R.YFGNFGNLYN(+.98)AAAIMGNPMVAK.H 1.17 19.60 788.7247 132.61 - 135.46 3 7.5E4 133.29 42 63 N Deamidation (NQ)
K.NMDDLKATYAELSVLHSEK.L Y 0.50 8.50 722.0305 105.34 - 107.81 3 7.4E4 106.37 78 96 Y
K.MDYEVVGPAALTR.C 0.18 1.77 711.3630 92.63 - 103.23 2 7.3E4 99.30 19 31 N
L.IVYPWTQR.Y 1.51 6.65 531.7952 85.11 - 88.57 2 6.4E4 87.03 34 41 N
R.CLIVYPWTQR.Y 0.14 0.60 639.8413 117.07 - 125.88 2 6.4E4 120.21 32 41 N
K.NMDDLKATYAELSVLHSEK.L Y 0.56 8.25 541.7752 105.48 - 107.75 4 6.3E4 106.47 78 96 Y
K.HGTTILHGLDR.G 1.97 16.46 1219.6657 46.72 - 53.88 1 6.2E4 49.88 64 74 N
W.TDFER.S 1.30 6.65 334.1595 29.60 - 33.24 2 5.7E4 31.55 5 9 N
K.LHVDPDNFK.L 1.85 17.04 1084.5536 52.93 - 58.36 1 5.6E4 55.51 97 105 N
R.C(+43.01)(+57.02)LIVYPWTQR.Y 1.60 2.36 689.8589 129.86 - 131.39 2 5.6E4 130.51 32 41 N Carbamylation; Carbamidomethylation
R.CLIVYPWTQR.Y 1.51 0.74 426.8986 113.19 - 117.69 3 5.2E4 114.81 32 41 N
M.VVWTDFER.S 0.43 1.39 526.2714 95.84 - 106.07 2 4.8E4 100.66 2 9 N
K.N(+43.01)MDDLK.A 0.58 8.71 778.3505 45.31 - 51.60 1 4.6E4 48.96 78 83 N Carbamylation
R.STIQDIFSKMDYEVVGPAALTR.C 1.74 4.09 814.4249 132.50 - 133.50 3 4.2E4 133.13 10 31 N
K.LLSDCLTIVVAAK.L 0.58 8.66 673.3922 130.25 - 136.91 2 4.2E4 134.30 106 118 N
K.LLSDCLTIVVAAK.L 0.38 5.45 673.3988 128.60 - 136.30 2 4E4 131.41 106 118 N
K.A(+43.01)TYAELSVLHSEK.L 0.66 8.16 745.8856 89.43 - 93.58 2 3.9E4 92.35 84 96 N Carbamylation
K.N(+43.01)MDDLK.A 0.95 4.54 778.3531 42.57 - 52.45 1 3.9E4 46.57 78 83 N Carbamylation
K.FLAVVVSSLGR.Q 0.49 7.92 574.3496 124.51 - 134.18 2 3.9E4 127.18 134 144 N
R.STIQDIFSK.M 0.10 1.25 519.7831 92.40 - 101.01 2 3.8E4 96.10 10 18 N
R.C(+43.01)LIVYPWTQR.Y 1.44 1.26 661.3470 133.06 - 134.20 2 3.7E4 133.56 32 41 N Carbamylation
N.AAAIMGNPMVAK.H 0.48 8.01 587.3174 65.34 - 70.40 2 3.2E4 68.80 52 63 N
R.CLIVYPWTQR.Y 1.50 0.02 1278.6764 113.19 - 117.86 1 3.1E4 114.80 32 41 N
K.HGTTILHGLDR.G 0.50 7.91 305.6714 46.55 - 53.74 4 3E4 50.65 64 74 N
R.CLIVYPWTQR.Y 0.78 1.65 639.8455 126.47 - 132.09 2 2.9E4 128.66 32 41 N
R.C(-1.01)LIVYPWTQR.Y 1.13 0.76 639.3536 127.36 - 129.01 2 2.9E4 128.22 32 41 N Half of a disulfide bridge
K.AFTGEVQAAFQK.F 1.06 2.10 648.8274 113.58 - 118.26 2 2.8E4 115.65 122 133 N
R.C(+42.01)LIVYPWTQR.Y 1.38 0.44 660.8508 131.21 - 133.67 2 2.7E4 132.18 32 41 N Acetylation (Protein N-term)
K.AFTGEVQAAFQK.F 0.37 3.54 648.8366 101.54 - 107.64 2 2.6E4 103.99 122 133 N
K.AFTGEVQAAFQK.F 1.16 8.82 1296.6663 80.31 - 85.04 1 2.6E4 81.19 122 133 N
K.A(+43.01)FTGEVQAAFQK.F 0.28 3.46 670.3365 115.98 - 119.31 2 2.6E4 116.95 122 133 N Carbamylation
K.A(+43.01)FTGEVQAAFQK.F 0.14 5.73 670.3449 115.30 - 120.13 2 2.5E4 116.61 122 133 N Carbamylation
R.C(+58.01)LIVYPWTQR.Y 1.13 3.06 668.8454 132.43 - 134.61 2 2.2E4 133.70 32 41 N Carboxymethyl
K.MDYEVVGPAALTR.C 0.24 1.57 711.3618 101.59 - 108.74 2 2.2E4 104.47 19 31 N
R.C(+57.02)LIVYPWTQR.Y 1.64 5.92 445.9062 109.86 - 112.63 3 2.1E4 111.56 32 41 N Carbamidomethylation
R.STIQDIFSK(+43.01).M 1.27 0.18 541.2867 108.13 - 111.17 2 2.1E4 109.95 10 18 N Carbamylation
R.C(+42.01)LIVYPWTQR.Y 1.67 0.89 440.9054 120.29 - 123.07 3 2.1E4 121.78 32 41 N Acetylation (Protein N-term)
Y.FGNFGNLYNAAAIMGNPMVAK.H 1.57 26.04 734.0344 131.72 - 132.74 3 2.1E4 132.14 43 63 N
K.AFTGEVQAAFQK.F 0.13 1.68 648.8351 84.02 - 91.28 2 1.9E4 87.28 122 133 N
K.N(+43.01)MDDLK.A 0.60 9.03 389.6783 45.41 - 51.23 2 1.8E4 49.23 78 83 N Carbamylation
F.GNLYNAAAIMGNPMVAK.H 0.39 7.33 867.9447 108.81 - 110.26 2 1.7E4 109.49 47 63 N
M.VVWTDFER.S 0.06 0.10 526.2700 88.00 - 97.64 2 1.7E4 93.98 2 9 N
R.C(+43.01)(+57.02)LIVYPWTQR.Y 1.06 2.83 689.8595 108.13 - 111.26 2 1.6E4 109.71 32 41 N Carbamylation; Carbamidomethylation
R.CLIVYPWTQR.Y 0.07 1.79 639.8458 117.13 - 124.15 2 1.5E4 120.25 32 41 N
K.AFTGEVQAAFQK.F 0.20 3.30 648.8279 92.09 - 98.62 2 1.5E4 94.87 122 133 N
K.AFTGEVQAAFQK.F 0.32 5.84 648.8383 127.81 - 134.26 2 1.4E4 129.96 122 133 N
K.AFTGEVQAAFQK.F 0.03 0.76 648.8449 80.98 - 87.44 2 1.4E4 83.52 122 133 N
K.FLAVVVSSLGR.Q 0.10 5.69 574.3427 127.00 - 135.62 2 1.3E4 131.59 134 144 N
Y.A(+43.01)ELSVLHSEK.L 0.13 5.84 578.3082 70.93 - 73.48 2 1.3E4 72.28 87 96 N Carbamylation
R.CLIVYPWTQR.Y 0.15 3.98 639.8403 121.61 - 127.62 2 1.3E4 125.75 32 41 N
K.AFTGEVQAAFQK.F 0.28 3.88 648.8382 78.81 - 80.91 2 1.2E4 79.99 122 133 N
R.YFGNFGNLYNAAAIMGNP(+15.99)MVAK.H 0.69 8.75 793.7239 130.95 - 132.28 3 1.2E4 131.46 42 63 N Hydroxylation [P]
K.FLAVVVSSLGR.Q 0.76 10.40 383.2340 108.55 - 111.19 3 1.1E4 109.09 134 144 N
K.FLAVVVSSLGR.Q 0.50 8.68 574.3502 121.64 - 129.23 2 1.1E4 124.16 134 144 N
C.LIVYPWTQR.Y 0.47 0.28 588.3381 100.65 - 102.90 2 9.9E3 102.06 33 41 N
K.AFTGEVQAAFQK.F 0.14 5.55 648.8325 130.91 - 135.82 2 9.5E3 133.02 122 133 N
R.STIQDIFSK(+43.01)MDYEVVGPAALTR.C 0.97 0.04 828.7602 135.35 - 136.04 3 8.8E3 135.60 10 31 N Carbamylation
F.LAVVVSSLGR.Q 0.30 7.57 500.8139 77.14 - 78.71 2 8.7E3 77.59 135 144 N
R.C(+43.01)LIVYPWTQR.Y 1.44 0.50 441.2334 111.57 - 114.13 3 8.6E3 113.18 32 41 N Carbamylation
R.C(+43.01)(-1.01)LIVYPWTQR.Y 0.16 0.50 660.8482 131.74 - 135.22 2 8.3E3 133.73 32 41 N Carbamylation; Half of a disulfide bridge
N.LYNAAAIMGNPMVAK.H 0.62 8.88 521.9431 100.79 - 102.59 3 8.2E3 101.82 49 63 N
N.LYNAAAIMGNPMVAK.H 0.08 5.41 782.4195 98.61 - 101.48 2 7.9E3 99.89 49 63 N
K.ATYAELSVLHSEK.L 0.02 5.26 483.2482 75.06 - 78.51 3 7.6E3 76.26 84 96 N
K.AFTGEVQAAFQK.F 0.46 3.94 648.8396 117.17 - 121.36 2 7.6E3 119.79 122 133 N
Y.FGNFGNLYNAAAIMGNPMVAK.H 0.31 7.01 1100.5510 129.65 - 134.67 2 7.3E3 132.14 43 63 N
K.AFTGEVQAAFQK.F 0.01 5.25 648.8362 93.84 - 98.93 2 6.9E3 96.37 122 133 N
K.AFTGEVQAAFQK.F 0.10 2.88 648.8437 90.18 - 95.32 2 6.3E3 92.49 122 133 N
M.VVWTDFER.S 0.02 5.08 526.2707 98.14 - 103.69 2 5.9E3 99.12 2 9 N
R.CLIVYPWTQR.Y 0.09 5.72 639.8429 127.80 - 132.46 2 5.9E3 129.78 32 41 N
K.M(+15.99)DYEVVGPAALTR.C 0.08 0.05 719.3742 80.44 - 85.65 2 5.4E3 83.44 19 31 N Oxidation (M)
Y.N(+42.01)AAAIMGNPMVAK.H 0.08 0.35 665.3487 91.75 - 94.31 2 5.3E3 93.01 51 63 N Acetylation (Protein N-term)
K.LLSDCLTIVVAAK.L 0.43 8.21 449.2691 127.39 - 133.46 3 5.3E3 128.57 106 118 N
K.AFTGEVQAAFQK.F 0.17 6.47 648.8396 124.35 - 128.98 2 5.2E3 125.62 122 133 N
M(+43.01)VVWTDFER.S 0.55 2.05 613.2963 129.39 - 133.21 2 5.1E3 132.43 1 9 N Carbamylation
R.C(+43.01)LIVYPWTQR.Y 1.44 1.64 1321.6861 111.54 - 114.10 1 5E3 113.02 32 41 N Carbamylation
R.C(+43.01)(+45.99)LIVYPWTQR.Y 0.07 5.27 684.3336 113.43 - 115.46 2 4.9E3 114.08 32 41 N Carbamylation; Beta-methylthiolation
K.AFTG(sub A)EVQAAFQK.F 0.18 1.93 648.8400 111.62 - 116.98 2 4.6E3 114.48 122 133 N Mutation
R.STIQDIFSKMDYEVVGPAALTR.C 1.09 3.31 611.0729 132.81 - 133.38 4 4.6E3 133.10 10 31 N
K.M(+15.99)DY(+79.96)EVVGPAALTR.C 0.19 3.84 506.5534 112.21 - 113.56 3 4.6E3 113.03 19 31 N Oxidation (M); Sulfation
K.M(+43.01)DYEVVGPAALTR.C 0.04 5.40 732.8730 112.07 - 115.61 2 4.6E3 113.72 19 31 N Carbamylation
R.C(+43.01)(+45.99)LIVYPWTQR.Y 0.84 1.65 456.5640 112.77 - 115.30 3 4.3E3 114.09 32 41 N Carbamylation; Beta-methylthiolation
K.FLAVVVSSLGR.Q 0.20 3.08 574.3431 106.83 - 108.59 2 4.2E3 107.83 134 144 N
K.FLAVVVSSLGR.Q 0.29 6.72 574.3511 115.61 - 120.93 2 4E3 118.31 134 144 N
K.FLAVVVSSLGR.Q 0.45 7.47 574.3462 118.76 - 124.90 2 3.9E3 120.57 134 144 N
R.STIQDIFSK(+43.01).M 0.15 0.08 541.2779 106.07 - 110.26 2 3.8E3 108.53 10 18 N Carbamylation
R.YFGNFGNLYNAAAIMGNPMVAK.H 0.55 8.54 591.5436 133.10 - 133.56 4 3.6E3 133.32 42 63 N
R.C(-1.01)LIVYPWTQR.Y 0.03 0.02 639.3472 127.42 - 131.67 2 3.3E3 129.25 32 41 N Half of a disulfide bridge
K.M(+43.01)DYEVVGPAALTR.C 0.37 0.27 488.9160 111.63 - 116.66 3 3.1E3 113.24 19 31 N Carbamylation
K.ATYAELSVLHSEK.L 0.04 2.34 724.3871 69.81 - 71.89 2 2.2E3 70.55 84 96 N
K.FLAVVVSSLGR.Q 0.22 6.70 574.3539 133.41 - 136.88 2 1.3E3 135.56 134 144 N
K.LLSDCLTIVVAAK.L 0.05 5.42 449.2684 128.76 - 130.54 3 1.1E3 129.58 106 118 N
R.STIQDIFSK(+43.01)MDYEVVGPAALTR.C 0.12 0.09 828.7648 135.47 - 136.11 3 1.1E3 135.77 10 31 N Carbamylation
K.FLAVVVSSLGR.Q 0.03 5.32 574.3493 111.49 - 119.21 2 1.1E3 114.02 134 144 N
K.LLSDCLTIVVAAK.L 0.18 1.34 673.3983 132.25 - 136.91 2 619.3 135.50 106 118 N
R.C(+43.01)LIVYPWTQR.Y 0.02 0.72 661.3459 132.05 - 134.99 2 549.1 133.45 32 41 N Carbamylation
R.YFGNFGNLYNAAAIMGNPMVAK.H 0.02 3.37 1182.0629 130.83 - 133.86 2 281.8 132.33 42 63 N
total 141 peptides